Xponance Inc. Grows Stock Holdings in Humana Inc. (NYSE:HUM)

Xponance Inc. boosted its holdings in Humana Inc. (NYSE:HUM) by 0.8% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 17,649 shares of the insurance provider’s stock after buying an additional 137 shares during the period. Xponance Inc.’s holdings in Humana were worth $4,478,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Pzena Investment Management LLC grew its position in shares of Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock worth $915,736,000 after purchasing an additional 1,103,132 shares in the last quarter. Boston Partners grew its holdings in Humana by 435.8% during the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock valued at $279,236,000 after buying an additional 893,637 shares in the last quarter. FMR LLC raised its position in shares of Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after buying an additional 643,291 shares during the last quarter. Retirement Systems of Alabama lifted its holdings in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after buying an additional 192,801 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new position in shares of Humana during the third quarter worth $50,102,000. 92.38% of the stock is owned by institutional investors.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.37% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the topic of a number of research reports. StockNews.com downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday. JPMorgan Chase & Co. dropped their price target on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Barclays lifted their price objective on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Morgan Stanley lowered their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $285.68.

Humana Price Performance

Shares of HUM stock opened at $266.62 on Friday. The company has a market capitalization of $32.18 billion, a P/E ratio of 26.80, a P/E/G ratio of 2.05 and a beta of 0.57. The company’s 50-day simple moving average is $271.39 and its two-hundred day simple moving average is $278.13. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio (DPR) is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.